Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > JDRF tweeting about Sernova
View:
Post by Redbaron2211 on Jan 25, 2021 9:43pm

JDRF tweeting about Sernova

Wow thats some validation!  Nice, I wouldnt be suprised to see more JDRF funding incoming.    

For those that dont follow them on Twitter;


JDRF Canada
Posted 13:54 24 Jan 2021

@TweeterDee16 We too are excited by Sernova’s progress in the area of cell therapies for T1D! We have been supporting them since 2016 & continue to provide funding for the ongoing clinical trial. We look forward to reporting back to the community about more progress from Sernova in the future!
 

JDRF is so proud to be a significant funder of this clinical trial, as we mark the centenary of the discovery of insulin this year. It is through investments in this type of research that we will move #beyondinsulin and accelerate towards a cure. https://t.co/J9puvT40Kn

theglobeandmail.com/business/artic…


 

Comment by rixpix on Jan 25, 2021 11:09pm
Their backing makes Sernova even more credible. Glta of us..... 
Comment by MedStocks2 on Jan 26, 2021 8:57am
@Red JDRF makes life interesting. Surely they must be realizing that Viacyte was the wrong horse. JDRF must surely recognize Sernovas value even as a tool to attract donations. Regardless of all the Johnny come lately opinions, the bottom line is that no other company has been able to achieve durable insulin independence! The numpties on the board keep calling everyone pumpers, but what we really ...more  
Comment by Redbaron2211 on Jan 26, 2021 2:44pm
Med agree, all those years the attention was on Viacyte and that focus is starting to shift, cant ignore the science.   JDRF can be thought of as a sentiment tracker for TD1 cure.     I enjoyed the quality times we have all had over the years. It's actually engaging to discuss something with longs that have a deep understanding of the science and potential here ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities